Suggestions

Du même auteur

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

Archive ouverte | Tarantino, P. | CCSD

International audience

Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?

Archive ouverte | Valenza, C. | CCSD

International audience. For patients with hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative (HR+/HER2−) metastatic breast cancer (mBC) progressed on first-line endocrine therapy plus...

Corrigendum to “3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)” [Breast 31 (February 2017) 244–259]

Archive ouverte | Cardoso, F. | CCSD

International audience

Chargement des enrichissements...